A carregar...
Adjuvant endocrine therapy for postmenopausal breast cancer in the era of aromatase inhibitors: an update
There is overwhelming evidence that optimal adjuvant endocrine therapy for hormone sensitive breast cancer in postmenopausal women should include a third generation aromatase inhibitor (AI). On current evidence, adjuvant anstrozole or letrozole should be used upfront in such patients especially in t...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2006
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1586206/ https://ncbi.nlm.nih.gov/pubmed/16981992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7800-3-31 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|